Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Capital Employed (2016 - 2025)

Voyager Therapeutics' Return on Capital Employed history spans 11 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 13.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, up 13.0%, while the annual FY2025 figure was 0.08%, 17.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.1% at Voyager Therapeutics, up from 0.52% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.41% in Q1 2023 and bottomed at 0.65% in Q1 2022.
  • The 5-year median for Return on Capital Employed is 0.24% (2024), against an average of 0.21%.
  • The largest annual shift saw Return on Capital Employed plummeted -76bps in 2021 before it soared 106bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.53% in 2021, then rose by 3bps to 0.52% in 2022, then skyrocketed by 121bps to 0.11% in 2023, then crashed by -313bps to 0.23% in 2024, then soared by 56bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Return on Capital Employed are 0.1% (Q4 2025), 0.52% (Q3 2025), and 0.42% (Q2 2025).